Benzinga | Aug 6, 2020 05:40PM EDT

CytomX Therapeutics Q2 EPS $(0.34) Up From $(0.64) YoY, Sales $16.61M Up From $9.01M YoY

CytomX Therapeutics (NASDAQ:CTMX) reported quarterly losses of $(0.34) per share. This is a 46.88 percent increase over losses of $(0.64) per share from the same period last year. The company reported $16.61 million in sales this quarter. This is a 84.27 percent increase over sales of $9.01 million the same period last year.